Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023
March 29, 2024 06:15 ET
|
Guardion Health Sciences, Inc.
Viactiv® Product Line Generated Net Revenues of Approximately $11.9 Million for the Year Ended December 31, 2023, an Increase of Approximately 12% as Compared to the Year Ended December 31, 2022 ...